Development of amphoteric alginate/aminated chitosan coated microbeads for oral protein delivery von Omer, A.M., Tamer, T.M., Hassan, M.A., Rychter, P., Mohy Eldin, M.S., Koseva, N.

Volltext

Prediction studies of environment-friendly biodegradable polymeric packaging based on PLA. Influence of specimens’ thickness on the hydrolytic degradation profile von Sikorska, W., Musioł, M., Rydz, J., Zięba, M., Rychter, P., Lewicka, K., Šiškova, A., Mosnáčková, K., Kowalczuk, M., Adamus, G.

Volltext

Hazardous ecotoxicological impact of two commonly used nitrofuran-derived antibacterial drugs: Furazolidone and nitrofurantoin von Lewkowski, Jarosław, Rogacz, Diana, Rychter, Piotr

Volltext

Synthesis and ecotoxicological impact of ferrocene-derived amino-phosphonates using a battery of bioassays von Lewkowski, J., Karpowicz, R., Morawska, M., Rychter, P., Rogacz, D., Lewicka, K., Dobrzyński, P.

Volltext

Synthesis and ecotoxicological impact of ferrocene-derived amino-phosphonates using a battery of bioassaysElectronic supplementary information (ESI) available: NMR spectra of imine... von Lewkowski, J, Karpowicz, R, Morawska, M, Rychter, P, Rogacz, D, Lewicka, K, Dobrzy ski, P

Volltext

Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - the impact of fibrosarcomatous transformation von Rutkowski, Piotr, Klimczak, Anna, Ługowska, Iwona, Jagielska, Beata, Wągrodzki, Michal, Dębiec-Rychter, Maria, Pieńkowska-Grela, Barbara, Świtaj, Tomasz

Volltext

Main Repositories and Databases Used in Ewing Sarcoma Research von Debiec-Rychter, Maria

Volltext

In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets von Arbajian, Elsa, Puls, Florian, Antonescu, Cristina R, Amary, Fernanda, Sciot, Raf, Debiec-Rychter, Maria, Sumathi, Vaiyapuri P, Järås, Marcus, Magnusson, Linda, Nilsson, Jenny, Hofvander, Jakob, Mertens, Fredrik

Volltext

Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases von Suster, David, Michal, Michael, Huang, Huiya, Ronen, Shira, Springborn, Stephanie, Debiec-Rychter, Maria, Billings, Steven D., Goldblum, John R., Rubin, Brian P., Michal, Michal, Suster, Saul, Mackinnon, A. Craig

Volltext

Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases von Lierman, E, Smits, S, Cools, J, Dewaele, B, Debiec-Rychter, M, Vandenberghe, P

Volltext

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection von Rutkowski, P, Dębiec-Rychter, M, Nowecki, ZI, Michej, W, Symonides, M, Ptaszynski, K, Ruka, W

Volltext

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase I... von Schöffski, P., Wozniak, A., Kasper, B., Aamdal, S., Leahy, M.G., Rutkowski, P., Bauer, S., Gelderblom, H., Italiano, A., Lindner, L.H., Hennig, I., Strauss, S., Zakotnik, B., Anthoney, A., Albiges, L., Blay, J.-Y., Reichardt, P., Sufliarsky, J., van der Graaf, W.T.A., Debiec-Rychter, M., Sciot, R., Van Cann, T., Marréaud, S., Raveloarivahy, T., Collette, S., Stacchiotti, S.

Volltext

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101... von Schöffski, P., Wozniak, A., Stacchiotti, S., Rutkowski, P., Blay, J.-Y., Lindner, L.H., Strauss, S.J., Anthoney, A., Duffaud, F., Richter, S., Grünwald, V., Leahy, M.G., Reichardt, P., Sufliarsky, J., van der Graaf, W.T., Sciot, R., Debiec-Rychter, M., van Cann, T., Marréaud, S., Lia, M., Raveloarivahy, T., Collette, L., Bauer, S.

Volltext

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials von Rutkowski, Piotr, Van Glabbeke, Martine, Rankin, Cathryn J, Ruka, Wlodzimierz, Rubin, Brian P, Debiec-Rychter, Maria, Lazar, Alexander, Gelderblom, Hans, Sciot, Raf, Lopez-Terrada, Dolores, Hohenberger, Peter, van Oosterom, Allan T, Schuetze, Scott M

Volltext

Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate von PRENEN, Hans, COOLS, Jan, MENTENS, Nicole, FOLENS, Cedric, SCIOT, Raf, SCHÖFFSKI, Patrick, VAN OOSTEROM, Allan, MARYNEN, Peter, DEBIEC-RYCHTER, Maria

Volltext

Constraint on the matter–antimatter symmetry-violating phase in neutrino oscillations von Abe, K., Akutsu, R., Ali, A., Alt, C., Andreopoulos, C., Anthony, L., Antonova, M., Aoki, S., Ariga, A., Arihara, T., Asada, Y., Ashida, Y., Atkin, E. T., Awataguchi, Y., Ban, S., Barbi, M., Barker, G. J., Barr, G., Barrow, D., Barry, C., Batkiewicz-Kwasniak, M., Beloshapkin, A., Bench, F., Berardi,  V., Berkman, S., Berns, L., Bhadra, S., Bienstock, S., Blondel, A., Bolognesi, S., Bourguille, B., Boyd, S. B., Brailsford, D., Bravar, A., Berguño, D. Bravo, Bronner, C., Bubak, A., Avanzini, M. Buizza, Calcutt, J., Campbell, T., Cao, S., Cartwright, S. L., Catanesi, M. G., Cervera, A., Chappell, A., Checchia, C., Cherdack, D., Chikuma, N., Cicerchia, M., Christodoulou, G., Coleman, J., Collazuol, G., Cook, L., Coplowe, D., Cudd, A., Dabrowska, A., De Rosa, G., Dealtry, T., Denner, P. F., Dennis, S. R., Densham, C., Di Lodovico, F., Dokania, N., Dolan, S., Doyle, T. A., Drapier, O., Dumarchez, J., Dunne, P., Eguchi, A., Eklund, L., Emery-Schrenk, S., Ereditato, A., Fernandez, P., Feusels, T., Finch, A. J., Fiorentini, G. A., Fiorillo, G., Francois, C., Friend, M., Fujii, Y., Fujita, R., Fukuda, D., Fukuda, R., Fukuda, Y., Fusshoeller, K., Gameil, K., Giganti, C., Golan, T., Gonin, M., Gorin, A., Guigue, M., Hadley, D. R., Haigh, J. T., Hamacher-Baumann, P., Hartz, M., Hasegawa, T., Hassani, S., Hastings, N. C., Hayashino, T., Hayato, Y.

Volltext

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants von Debiec-Rychter, Maria, Cools, Jan, Dumez, Herlinde, Sciot, Raf, Stul, Michel, Mentens, Nicole, Vranckx, Hilde, Wasag, Bartosz, Prenen, Hans, Roesel, Johannes, Hagemeijer, Anne, Van Oosterom, Allan, Marynen, Peter

Volltext

Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study... von Bujko, K., Wyrwicz, L., Rutkowski, A., Malinowska, M., Pietrzak, L., Kryński, J., Olędzki, J., Kuśnierz, J., Zając, L., Szczepkowski, M., Tarnowski, W., Kosakowska, E., Zwoliński, J., Winiarek, M., Bęczkowska, K., Polkowski, W., Styliński, R., Wierzbicki, R., Bury, P., Jankiewicz, M., Paprota, K., Lewicka, M., Ciseł, B., Skórzewska, M., Maciejczyk, A., Kapturkiewicz, B., Dybko, A., Hajac, Ł., Leśniak, T., Zygulska, J., Jantner, D., Chudyba, E., Las-Jankowska, M., Jankowski, M., Kołodziejski, L., Żelazowska-Omiotek, U., Kępka, L., Kolb-Sielecki, J., Toczko, Z., Fedorowicz, Z., Dziki, A., Nawrocki, G., Sopyło, R., Markiewicz, W., Kędzierawski, P., Wydmański, J., Albiński, J., Banaś, R., Chmielowska, E., Bal, W., Baszczyk-Mnich, J., Bialas, M., Borowiec, T., Cencelewicz, A., Chomik, K., Chwaliński, M., Ciepela, I., Florek, A., Górnicki, A., Jeziorski, K., Józwicki, W., Kobiela, J., Koda, M., Kołodziej, P., Kruszewski, P., Kryj, M., Kuciel-Lisiecka, G., Kwiatkowski, R., Lachowski, A., Liszka-Dalecki, P., Majewski, A., Majewski, W., Majsak, T., Maka, D., Malka, M., Mazurkiewicz, A., Morawiec, J., Nogal, E., Olejniczak, M., Olkowski, D., Ostrowska-Cichocka, K., Pietruszka, M., Piotrkowski, G., Plewicka, M., Porzuczek-Zuziak, D., Reszke, J., Rychter, A., Sadowski, J., Serkies, K., Srutek, E., Szóstak, B., Tuziak, T., Tyralik, D., Skoczylas, J., Wachua, E., Wandzel, P., Winkler-Spytkowska, B., Wojtasik, P., Wroński, K., Zygulski, I.

Volltext

Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience von Wozniak, A., Rutkowski, P., Piskorz, A., Ciwoniuk, M., Osuch, C., Bylina, E., Sygut, J., Chosia, M., Rys, J., Urbanczyk, K., Kruszewski, W., Sowa, P., Siedlecki, J., Debiec-Rychter, M., Limon, J.

Volltext

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification von Cornillie, J., Wozniak, A., Li, H., Gebreyohannes, Y. K., Wellens, J., Hompes, D., Debiec-Rychter, M., Sciot, R., Schöffski, P.

Volltext